Ignite Creation Date:
2024-05-06 @ 4:10 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04890197
Status:
UNKNOWN
Last Update Posted:
2021-05-18
First Post:
2021-05-05
Brief Title:
Tahini and Dermatitis in Breast Cancer
Sponsor:
National Nutrition and Food Technology Institute
Organization:
National Nutrition and Food Technology Institute
Study Overview
Official Title:
The Effects of Tahini Consumption on Radiotherapy Induced Dermatitis in Breast Cancer - A Pilot Study
Status:
UNKNOWN
Status Verified Date:
2021-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aimed to investigate the effect of tahini on acute radiation dermatitis in breast cancer BC patients undergoing radiotherapy RT
50 eligible BC patients will randomly assign to consume tahini 48 gr per day during and 1 week after RT or with no intervention control group The radiation dermatitis will be assessed weekly according to the Radiation Therapy Oncology Group European Organization for Research and Treatment of Cancer RTOGEORTC scales
50 eligible BC patients will randomly assign to consume tahini 48 gr per day during and 1 week after RT or with no intervention control group The radiation dermatitis will be assessed weekly according to the Radiation Therapy Oncology Group European Organization for Research and Treatment of Cancer RTOGEORTC scales
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None